ASTRAZENECA PLC (ZEG.DE) Fundamental Analysis & Valuation

FRA:ZEG • GB0009895292

Current stock price

160.7 EUR
+0.95 (+0.59%)
Last:

This ZEG.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ZEG.DE Profitability Analysis

1.1 Basic Checks

  • ZEG had positive earnings in the past year.
  • In the past year ZEG had a positive cash flow from operations.
  • Each year in the past 5 years ZEG has been profitable.
  • ZEG had a positive operating cash flow in each of the past 5 years.
ZEG.DE Yearly Net Income VS EBIT VS OCF VS FCFZEG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

1.2 Ratios

  • ZEG has a Return On Assets of 8.96%. This is in the better half of the industry: ZEG outperforms 63.64% of its industry peers.
  • With a decent Return On Equity value of 21.01%, ZEG is doing good in the industry, outperforming 65.45% of the companies in the same industry.
  • ZEG's Return On Invested Capital of 13.63% is fine compared to the rest of the industry. ZEG outperforms 65.45% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZEG is in line with the industry average of 14.21%.
  • The 3 year average ROIC (12.48%) for ZEG is below the current ROIC(13.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.96%
ROE 21.01%
ROIC 13.63%
ROA(3y)7.2%
ROA(5y)5.03%
ROE(3y)17.82%
ROE(5y)12.53%
ROIC(3y)12.48%
ROIC(5y)10.5%
ZEG.DE Yearly ROA, ROE, ROICZEG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • ZEG has a better Profit Margin (17.41%) than 69.09% of its industry peers.
  • In the last couple of years the Profit Margin of ZEG has grown nicely.
  • Looking at the Operating Margin, with a value of 23.86%, ZEG is in line with its industry, outperforming 58.18% of the companies in the same industry.
  • ZEG's Operating Margin has improved in the last couple of years.
  • ZEG's Gross Margin of 81.31% is amongst the best of the industry. ZEG outperforms 85.45% of its industry peers.
  • ZEG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.86%
PM (TTM) 17.41%
GM 81.31%
OM growth 3Y6.24%
OM growth 5Y7.63%
PM growth 3Y32.91%
PM growth 5Y7.71%
GM growth 3Y0.34%
GM growth 5Y0.28%
ZEG.DE Yearly Profit, Operating, Gross MarginsZEG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ZEG.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZEG is still creating some value.
  • The number of shares outstanding for ZEG remains at a similar level compared to 1 year ago.
  • ZEG has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZEG has been reduced compared to a year ago.
ZEG.DE Yearly Shares OutstandingZEG.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ZEG.DE Yearly Total Debt VS Total AssetsZEG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 3.77 indicates that ZEG is not in any danger for bankruptcy at the moment.
  • ZEG has a Altman-Z score of 3.77. This is comparable to the rest of the industry: ZEG outperforms 54.55% of its industry peers.
  • ZEG has a debt to FCF ratio of 3.42. This is a good value and a sign of high solvency as ZEG would need 3.42 years to pay back of all of its debts.
  • The Debt to FCF ratio of ZEG (3.42) is better than 63.64% of its industry peers.
  • ZEG has a Debt/Equity ratio of 0.55. This is a neutral value indicating ZEG is somewhat dependend on debt financing.
  • ZEG has a better Debt to Equity ratio (0.55) than 61.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.42
Altman-Z 3.77
ROIC/WACC1.49
WACC9.14%
ZEG.DE Yearly LT Debt VS Equity VS FCFZEG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • ZEG has a Current Ratio of 0.94. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZEG has a Current ratio of 0.94. This is amonst the worse of the industry: ZEG underperforms 81.82% of its industry peers.
  • ZEG has a Quick Ratio of 0.94. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ZEG (0.72) is worse than 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.72
ZEG.DE Yearly Current Assets VS Current LiabilitesZEG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ZEG.DE Growth Analysis

3.1 Past

  • The earnings per share for ZEG have decreased by -1.34% in the last year.
  • ZEG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.04% yearly.
  • ZEG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.63%.
  • ZEG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.15% yearly.
EPS 1Y (TTM)-1.34%
EPS 3Y6.74%
EPS 5Y15.04%
EPS Q2Q%-49.28%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y9.82%
Revenue growth 5Y17.15%
Sales Q2Q%4.11%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.20% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.82% on average over the next years.
EPS Next Y30.41%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
EPS Next 5Y15.2%
Revenue Next Year6.06%
Revenue Next 2Y5.93%
Revenue Next 3Y6.22%
Revenue Next 5Y6.82%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZEG.DE Yearly Revenue VS EstimatesZEG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
ZEG.DE Yearly EPS VS EstimatesZEG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. ZEG.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.53, ZEG is valued on the expensive side.
  • ZEG's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.77, ZEG is valued at the same level.
  • A Price/Forward Earnings ratio of 18.05 indicates a rather expensive valuation of ZEG.
  • ZEG's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 21.75. ZEG is around the same levels.
Industry RankSector Rank
PE 23.53
Fwd PE 18.05
ZEG.DE Price Earnings VS Forward Price EarningsZEG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ZEG.
  • ZEG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 34.09
EV/EBITDA 16.14
ZEG.DE Per share dataZEG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ZEG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ZEG may justify a higher PE ratio.
  • A more expensive valuation may be justified as ZEG's earnings are expected to grow with 17.63% in the coming years.
PEG (NY)0.77
PEG (5Y)1.56
EPS Next 2Y20.69%
EPS Next 3Y17.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. ZEG.DE Dividend Analysis

5.1 Amount

  • ZEG has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
  • ZEG's Dividend Yield is comparable with the industry average which is at 1.96.
  • ZEG's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • The dividend of ZEG has a limited annual growth rate of 3.33%.
Dividend Growth(5Y)3.33%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 48.62% of the earnings are spent on dividend by ZEG. This is a bit on the high side, but may be sustainable.
  • ZEG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP48.62%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
ZEG.DE Yearly Income VS Free CF VS DividendZEG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ZEG.DE Dividend Payout.ZEG.DE Dividend Payout, showing the Payout Ratio.ZEG.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ZEG.DE Fundamentals: All Metrics, Ratios and Statistics

ASTRAZENECA PLC

FRA:ZEG (2/5/2026, 7:00:00 PM)

160.7

+0.95 (+0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners49.17%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap249.13B
Revenue(TTM)58.74B
Net Income(TTM)10.22B
Analysts82.94
Price Target175.52 (9.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2.7
Dividend Growth(5Y)3.33%
DP48.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.37%
Min EPS beat(2)-60.38%
Max EPS beat(2)9.64%
EPS beat(4)2
Avg EPS beat(4)-12.23%
Min EPS beat(4)-60.38%
Max EPS beat(4)9.64%
EPS beat(8)4
Avg EPS beat(8)-5.74%
EPS beat(12)7
Avg EPS beat(12)-2.63%
EPS beat(16)11
Avg EPS beat(16)-0.36%
Revenue beat(2)1
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-4.83%
Max Revenue beat(2)2.2%
Revenue beat(4)1
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-0.54%
Revenue beat(12)5
Avg Revenue beat(12)-0.86%
Revenue beat(16)6
Avg Revenue beat(16)-0.78%
PT rev (1m)5.49%
PT rev (3m)12.4%
EPS NQ rev (1m)-1.75%
EPS NQ rev (3m)-1.48%
EPS NY rev (1m)1.58%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 23.53
Fwd PE 18.05
P/S 5.03
P/FCF 34.09
P/OCF 20.28
P/B 6.07
P/tB N/A
EV/EBITDA 16.14
EPS(TTM)6.83
EY4.25%
EPS(NY)8.9
Fwd EY5.54%
FCF(TTM)4.71
FCFY2.93%
OCF(TTM)7.93
OCFY4.93%
SpS31.94
BVpS26.46
TBVpS-5.67
PEG (NY)0.77
PEG (5Y)1.56
Graham Number63.7726 (-60.32%)
Profitability
Industry RankSector Rank
ROA 8.96%
ROE 21.01%
ROCE 16.8%
ROIC 13.63%
ROICexc 14.63%
ROICexgc 59.47%
OM 23.86%
PM (TTM) 17.41%
GM 81.31%
FCFM 14.76%
ROA(3y)7.2%
ROA(5y)5.03%
ROE(3y)17.82%
ROE(5y)12.53%
ROIC(3y)12.48%
ROIC(5y)10.5%
ROICexc(3y)13.49%
ROICexc(5y)11.39%
ROICexgc(3y)81.92%
ROICexgc(5y)83.55%
ROCE(3y)15.36%
ROCE(5y)12.92%
ROICexgc growth 3Y-25.55%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y9.13%
ROICexc growth 5Y9.72%
OM growth 3Y6.24%
OM growth 5Y7.63%
PM growth 3Y32.91%
PM growth 5Y7.71%
GM growth 3Y0.34%
GM growth 5Y0.28%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.42
Debt/EBITDA 1.36
Cap/Depr 103%
Cap/Sales 10.05%
Interest Coverage 10.65
Cash Conversion 73.79%
Profit Quality 84.79%
Current Ratio 0.94
Quick Ratio 0.72
Altman-Z 3.77
F-Score7
WACC9.14%
ROIC/WACC1.49
Cap/Depr(3y)80.57%
Cap/Depr(5y)64.46%
Cap/Sales(3y)8.93%
Cap/Sales(5y)7.69%
Profit Quality(3y)99.49%
Profit Quality(5y)775.68%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.34%
EPS 3Y6.74%
EPS 5Y15.04%
EPS Q2Q%-49.28%
EPS Next Y30.41%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
EPS Next 5Y15.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y9.82%
Revenue growth 5Y17.15%
Sales Q2Q%4.11%
Revenue Next Year6.06%
Revenue Next 2Y5.93%
Revenue Next 3Y6.22%
Revenue Next 5Y6.82%
EBIT growth 1Y10.05%
EBIT growth 3Y16.67%
EBIT growth 5Y26.09%
EBIT Next Year23.4%
EBIT Next 3Y12.45%
EBIT Next 5Y11.39%
FCF growth 1Y19.18%
FCF growth 3Y6.21%
FCF growth 5Y31.64%
OCF growth 1Y22.88%
OCF growth 3Y14.12%
OCF growth 5Y24.88%

ASTRAZENECA PLC / ZEG.DE Fundamental Analysis FAQ

What is the fundamental rating for ZEG stock?

ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.


What is the valuation status of ASTRAZENECA PLC (ZEG.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.


How profitable is ASTRAZENECA PLC (ZEG.DE) stock?

ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.


What is the valuation of ASTRAZENECA PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 23.53 and the Price/Book (PB) ratio is 6.07.


What is the earnings growth outlook for ASTRAZENECA PLC?

The Earnings per Share (EPS) of ASTRAZENECA PLC (ZEG.DE) is expected to grow by 30.41% in the next year.